
Chemotherapy-induced Peripheral Neuropathy
In chemotherapy, cumulative dose-limiting toxicity is a major problem due to the painful neuropathy induced by antineoplastic agents. When preclinically administered, these chemicals also produce sensory neuropathies consistent with those reported in patients. This is the case with oxaliplatin and paclitaxel-induced hypersensitivity.
Chemotherapy with anti-neoplastic agents such as oxaliplatin or paclitaxel often produces a dose-limiting painful peripheral neuropathy in cancer patients, characterized by dysesthesia, paresthesia, and spontaneous pain in the distal extremities. In rodents, both agents induce progressive neuronal degeneration, mechanical hypersensitivity, and cold allodynia through distinct primary mechanisms — DNA-adduct formation and mitochondrial dysfunction for oxaliplatin, microtubule dynamics impairment for paclitaxel — converging on shared peripheral (altered conduction velocity, mitochondrial dysfunction) and central (central sensitization) contributions to the pain phenotype.
Paclitaxel-induced chronic peripheral sensory neuropathy is modeled via repeated intraperitoneal injections (2 mg/kg x4), with mechanical and cold allodynia. Oxaliplatin-induced neuropathy is generated by a single intraperitoneal injection (10 mg/kg) in both mice and rats and produces mechanical allodynia of similar duration.
Both models persist for at least 2–3 weeks and are reversed by pregabalin, supporting their use for evaluating analgesic candidates against dose-limiting CIPN.

Latency to withdrawal behavior (s) in the cold plate test (15 °C) in different study groups. *, **, and *** indicate statistically significant difference with p<0.05, p<0.01 and p<0.001 respectively when compared to the Vehicle Group in the same timepoint. Values are shown as mean ± SEM.

Paw withdrawal threshold 50% (g) using von Frey filaments in different study groups. *, **, *** and **** indicate statistically significant difference with p<0.05, p<0.01, p<0.001 and p<0.0001 respectively when compared to the Oxal/ Vehicle group in the same timepoint. Values are shown as mean ± SEM.